Q32 Bio (QTTB) EBIT (2017 - 2026)
Q32 Bio's quarterly EBIT came in at -$7.7 million in Q1 2026, up 36.85% year-on-year from -$5.6 million in Q1 2025, and down 116.83% quarter-over-quarter from $45.9 million in Q4 2025.
Q32 Bio has reported EBIT for 10 years, with the latest figure at -$7.7 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 36.85% year-over-year to -$7.7 million; the trailing twelve-month figure through Mar 2026 stood at $21.4 million (up 133.72% YoY), and the FY2025 full-year result was $16.9 million, up 125.57% from the prior year.
- EBIT for Q1 2026 stood at -$7.7 million, down from $45.9 million in the prior quarter.
- The five-year high for EBIT was $97.9 million in Q4 2022, with the low at -$37.6 million in Q1 2022.
- Average EBIT over 5 years is -$6.2 million, with a median of -$12.2 million recorded in 2025.
- Year-over-year, EBIT tumbled 3285.96% in 2022 and soared 415.84% in 2025.
- Tracing QTTB's EBIT over 5 years: stood at $97.9 million in 2022, then plunged by 126.37% to -$25.8 million in 2023, then soared by 43.72% to -$14.5 million in 2024, then soared by 415.84% to $45.9 million in 2025, then plunged by 116.83% to -$7.7 million in 2026.
- The last three EBIT figures came in at -$7.7 million (Q1 2026), $45.9 million (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | -7.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.72 Mn |
| Dec 31, 2025 | 45.88 Mn |
| Sep 30, 2025 | -7.58 Mn |
| Jun 30, 2025 | -9.17 Mn |
| Mar 31, 2025 | -12.23 Mn |
| Dec 31, 2024 | -14.53 Mn |
| Sep 30, 2024 | -18.81 Mn |
| Jun 30, 2024 | -17.92 Mn |
| Mar 31, 2024 | -14.84 Mn |
| Dec 31, 2023 | -25.81 Mn |
| Sep 30, 2023 | -7.80 Mn |
| Jun 30, 2023 | -7.28 Mn |
| Mar 31, 2023 | -7.37 Mn |
| Dec 31, 2022 | 97.89 Mn |
| Sep 30, 2022 | -32.86 Mn |
| Jun 30, 2022 | -28.31 Mn |
| Mar 31, 2022 | -37.62 Mn |
| Dec 31, 2021 | 42.21 Mn |
| Sep 30, 2021 | -30.66 Mn |
| Jun 30, 2021 | -30.55 Mn |
| Mar 31, 2021 | -1.11 Mn |
| Dec 31, 2020 | -29.80 Mn |
| Sep 30, 2020 | -28.27 Mn |
| Jun 30, 2020 | -35.70 Mn |
| Mar 31, 2020 | -36.49 Mn |
| Dec 31, 2019 | -25.56 Mn |
| Sep 30, 2019 | -31.29 Mn |
| Jun 30, 2019 | -27.97 Mn |
| Mar 31, 2019 | -25.12 Mn |
| Dec 31, 2018 | -20.17 Mn |
| Sep 30, 2018 | -15.64 Mn |
| Jun 30, 2018 | -13.42 Mn |
| Mar 31, 2018 | -10.70 Mn |
| Dec 31, 2017 | -12.26 Mn |
| Sep 30, 2017 | -6.66 Mn |
| Jun 30, 2017 | -6.04 Mn |
| Mar 31, 2017 | -4.69 Mn |